AKAM vs CDNA · P/E 27, rev $2.17B vs rev $249.6M
Akamai Technologies Inc (AKAM) versus CareDx Inc (CDNA) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
CareDx Inc (CDNA) is a diagnostics & research company listed on US.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported CDNA revenue for 2026-06-30 was $249.6M. Net income was $113.4M. CDNA currently screens at market cap $1.18B.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. CDNA currently screens at market cap $1.18B.
Not investment advice. Open the AKAM and CDNA stock pages for the full models.
Not investment advice.